August 14, 2024

The feasibility of fat quantification by MRI-PDFF maps for assessing grading of NAFLD

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Non-alcoholic fatty liver disease (NAFLD) is a serious threat to human health, and the investigation for non-invasive biomarkers to quantify hepatic fat content appears to be crucial. In the study, PDFF was used to quantify liver fat content, assess the grade and degree of hepatic steatosis. PDFF was found to be effective in assessing fat content in NAFLD, which is expected to be used as a biomarker to assess the grading of steatosis in patients with NAFLD.

Me gusta

Guardar

Cite This Study

Qi et al. (Wed,) studied this question.

synapsesocial.com/papers/68e5c61db6db64358755c423 https://doi.org/https://doi.org/10.58530/2023/3151

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Mri Fat Quantography in Fattly Liver Patients2025
2Correlation between magnetic resonance imaging proton density fat fraction (MRI-PDFF) and liver biopsy to assess hepatic steatosis in obesity2024 · 16 citations
3Application and Advances of Non-in vasive Magnetic Resonance Proton Density Fat Fraction in Hepatic Steatosis2025 · 1 citations
4Assessment of Different Strategies for ROI-Based Measurements of Proton Density Fat Fraction in NAFLD2024
5MR Spectroscopy–derived Proton Density Fat Fraction Is Superior to Controlled Attenuation Parameter for Detecting and Grading Hepatic Steatosis2017 · 111 citations

Me gusta

Guardar